CRT 2025

Technology and Innovation

BRS DES and DCB Technologies

The Future of Drug-Eluting Treatments | A Look at PXTÂ Versus Sirolimus from Bench to Bedside Results

Speaker(s)

• 

  George Adams, MD MHS MBA FACC FSCAI

  Chief Medical Officer, Cordis
  Cordis, North Carolina, United States

  Disclosure information not submitted.